Why Tesla stock is crashing around 3% on Tuesday

Tesla shares fell sharply on Tuesday, tracking a broad market selloff that hit large technology stocks as investors fled riskier assets amid escalating trade tensions. The electric-vehicle maker’s stock was down around 3% in midday trading, moving in lockstep with the wider retreat from mega-cap technology names. The declines followed renewed tariff threats from President […]

CoreWeave CEO shrugs off three major AI infrastructure risks

The artificial intelligence (AI) boom has sparked major “euphoria” across industries – sending the benchmark S&P 500 index to a near 7,000 level. Still, some Wall Street experts continue to recommend caution, citing three major risks that could “derail” the sector in 2026: Smaller firms running out of capital Disruptive tech breakthroughs that reduce compute […]

WhiteBIT and Elina Svitolina announce strategic partnership during Australian Open

As the tennis world turns its attention to the opening Grand Slam of the season, Australian Open 2026, WhiteBIT, Europe’s largest cryptocurrency exchange by traffic, and Elina Svitolina — Olympic bronze medalist, Jean King Cup 2025 semifinalist and 19-time WTA singles champion — have announced a strategic partnership. The announcement comes at a key moment […]

Europe bulletin: BoE sounds alarm, UK’s big move on social media, Macron issues warning

Global markets may look serene, but beneath the surface, political risk is surging. Bank of England Governor Andrew Bailey is warning that geopolitical shocks, from trade escalation to threats against Fed independence, could trigger abrupt repricing with global consequences. Meanwhile, Germany’s ThyssenKrupp Marine Systems is upping the stakes in Canada’s submarine race with a sweeping […]

Evening digest: Bitcoin slips below 90K, gold hits records, Netflix goes all-cash on WBD

Markets are repricing power, not growth. Netflix just went all-cash on Warner Bros. Discovery at $27.75 a share, removing stock-risk and forcing Paramount into a credibility fight it can’t win. At the same time, geopolitics is overwhelming fundamentals: gold is ripping to fresh records as tariff threats around Greenland morph into a NATO stress test […]

What made Corvus stock double on Tuesday and is it sustainable?

Corvus Pharmaceuticals (NASDAQ: CRVS) shares more than doubled on Jan. 20 after announcing positive Phase 1 trial data for “soquelitinib” – its oral investigational drug for atopic dermatitis. Soquelitinib demonstrated strong efficacy in treatment-resistant patients and a “favourable” safety profile, sparking chatter about “best-in-class” potential in the massive dermatology market. Following today’s rally, Corvus stock […]